Showing results (871-880 of 932) with videos related to

Sort By:
Pageof 94
International Journal for Parasitology|June 16, 2007
Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas diseaseJuan M Burgos, Jaime Altcheh, Margarita Bisio, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 27, 2018
The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III TrialKenneth E Schmader, Myron J Levin, Katrijn Grupping, et al.
AIDS Research and Human Retroviruses|April 18, 2018
Low Rates of Vaccination for Herpes Zoster in Older People Living With HIVKristine M Erlandson, Amber Streifel, Alexander R Novin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 25, 2010
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years oldMyron J Levin, Anna-Barbara Moscicki, Lin-Ye Song, et al.
The American Journal of Tropical Medicine and Hygiene|December 16, 2005
Molecular diagnosis and typing of Trypanosoma cruzi populations and lineages in cerebral Chagas disease in a patient with AIDSJuan M Burgos, Sandra B Begher, Jorge M Freitas, et al.
Plos Pathogens|March 29, 2014
Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBVChristopher Chiu, Megan McCausland, John Sidney, et al.
The Lancet. Haematology|December 22, 2015
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics studyGiovanni Martinelli, Vivian G Oehler, Cristina Papayannidis, et al.
Genome Research|December 30, 1999
Physical mapping of a 670-kb region of chromosomes XVI and XVII from the human protozoan parasite Trypanosoma cruzi encompassing the genes for two immunodominant antigensM R Santos, H Lorenzi, P Porcile, et al.
Human Vaccines|November 4, 2011
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 yearsMark H Einstein, Mira Baron, Myron J Levin, et al.
The Journal of Infectious Diseases|June 6, 2023
Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant VariantsKevin M Tuffy, Bahar Ahani, Anastasia A Aksyuk, et al.
Pageof 94